Based
BOSTON, MASSACHUSETTS
BOSTON, MASSACHUSETTS
Industry group
Biotechnology
Biotechnology
Filings
3
3
Raised (new offerings)
$80M
$80M
Every filing
| Filed | Type | Amount sold | Total offering | Records |
|---|---|---|---|---|
| 2026-07-22 | New offering first sale 2026-07-13 | $50M | $50M | SEC filing |
| 2026-05-14 | New offering first sale 2026-05-04 | $30M | $30M | SEC filing |
| 2022-11-21 | Filing | — | — | SEC filing |
How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.
Every figure here is read from Cue Biopharma, Inc.'s own filings with the SEC. The people those filings name are on the team page.